102 EFFECTS OF SATAVAPTAN, AN ORAL VASOPRESSIN V2 RECEPTOR ANTAGONIST, ON MANAGEMENT OF ASCITES AND MORBIDITY IN LIVER CIRRHOSIS IN A LONG-TERM, PLACEBO-CONTROLLED STUDY

2009 ◽  
Vol 50 ◽  
pp. S42-S43 ◽  
Author(s):  
F. Wong ◽  
M. Bernardi ◽  
Y. Horsmans ◽  
Z. Cabrijan ◽  
H. Watson ◽  
...  
Keyword(s):  
Liver Cirrhosis ◽  
Receptor Antagonist ◽  
Controlled Study ◽  
Vasopressin V2 Receptor ◽  
V2 Receptor ◽  
Vasopressin V2 Receptor Antagonist ◽  
V2 Receptor Antagonist

Aquaretic and hormonal effects of a vasopressin V2 receptor antagonist after acute and long-term treatment in rats

2000 ◽  
Vol 394 (1) ◽  
pp. 131-138 ◽  
Author(s):  
Colette Lacour ◽  
Gérard Galindo ◽  
Françoise Canals ◽  
Danielle Segondy ◽  
Catherine Cazaubon ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Term Treatment ◽  
Hormonal Effects ◽  
Vasopressin V2 Receptor ◽  
Long Term Treatment ◽  
V2 Receptor ◽  
Vasopressin V2 Receptor Antagonist ◽  
V2 Receptor Antagonist

Effect of SR121463, a Selective Non-Peptide Vasopressin V2 Receptor Antagonist, in a Rabbit Model of Ocular Hypertension

2000 ◽  
Vol 16 (3) ◽  
pp. 203-216 ◽  
Author(s):  
FREDERIC LACHERETZ ◽  
ALAIN BARBIER ◽  
CLAUDINE SERRADEIL-LE GAL ◽  
PIERRE-PAUL ELENA ◽  
JEAN-PIERRE MAFFRAND ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Ocular Hypertension ◽  
Rabbit Model ◽  
Vasopressin V2 Receptor ◽  
V2 Receptor ◽  
Vasopressin V2 Receptor Antagonist ◽  
V2 Receptor Antagonist

scholarly journals OPC-31260, a nonpeptide vasopressin V2 receptor antagonist is a novel aquaretic agent

1992 ◽  
Vol 58 ◽  
pp. 195
Author(s):  
Shigeki Nakamura ◽  
Yoshitaka Yamamura ◽  
Hidenori Ogawa ◽  
Tomihiko Chihara ◽  
Toshiyuki Onogawa ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Vasopressin V2 Receptor ◽  
V2 Receptor ◽  
Vasopressin V2 Receptor Antagonist ◽  
V2 Receptor Antagonist

scholarly journals FP051DETERMINANTS OF URINE VOLUME IN ADPKD-PATIENTS USING THE VASOPRESSIN V2 RECEPTOR ANTAGONIST TOLVAPTAN

2018 ◽  
Vol 33 (suppl_1) ◽  
pp. i64-i65
Author(s):  
Bart Kramers ◽  
Judith Heida ◽  
Wendy Boertien ◽  
Maatje van Gastel ◽  
Esther Meijer ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Urine Volume ◽  
Vasopressin V2 Receptor ◽  
V2 Receptor ◽  
Vasopressin V2 Receptor Antagonist ◽  
V2 Receptor Antagonist

Vasopressin V2 Receptor Antagonist Inhibits Cardiac Remodeling with Old Myocardial Infarction in Rats

2011 ◽  
Vol 17 (9) ◽  
pp. S149-S150
Author(s):  
Takanori Yamazaki ◽  
Yasuhiro Nakamura ◽  
Yasukatsu Izumi ◽  
Akihisa Hanatani ◽  
Takashi Muro ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Receptor Antagonist ◽  
Cardiac Remodeling ◽  
Vasopressin V2 Receptor ◽  
Old Myocardial Infarction ◽  
V2 Receptor ◽  
Vasopressin V2 Receptor Antagonist ◽  
V2 Receptor Antagonist
Sign in / Sign up

Export Citation Format

Share Document